Delivery Order SPE2DP23D0001-SPE2D625F9X6Y
- Not listed
- The Defense Department's Medical Supply Chain division awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on May 20, 2025, with an ultimate completion date of August 5, 2025. This delivery order, contract number 4568321059, represents a child contract with no set-aside designation and will be performed in Ottawa, Ontario, Canada. CCC, a Crown corporation that serves as an intermediary facilitating government-to-government contracting between U.S. federal...
- This federal contract award, valued at $532,400.00, was issued by the Defense Logistics Agency Troop Support Medical to the prime contractor Canadian Commercial Corporation (CCC). CCC is a Crown corporation owned by the Government of Canada that facilitates military exports and international contracting opportunities for Canadian companies. The contract is for the delivery of Reactive Skin Decontamination Lotion (RSDL). CCC has subcontracted this work to Emergent Biosolutions Canada Inc., a...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for the supply of Inactive Skin Decontamination Lotion 21. This contract, valued at $1,648.86, is a firm fixed-price delivery order with an ultimate completion date of December 18, 2025. The contract carries no set-aside designation, reflecting CCC's role as a Crown corporation facilitating government-to-government contracting between U.S. federal agencies and...
- This federal contract award, valued at $96,800.00, was issued by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC) for the delivery of Reactive Skin Decontamination Lotion (RSDL). CCC is a Crown corporation owned by the Government of Canada that acts as a prime contractor to U.S. federal agencies, primarily the Department of Defense. The contract has a firm fixed-price delivery order structure with a completion date of December 14, 2016. CCC has subcontracted a...
- This is a $2,019.79 Firm Fixed Price delivery order contract awarded to Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada. The contract, awarded by the Defense Logistics Agency (DLA), is for the delivery of RSDL (Reactive Skin Decontamination Lotion) medical supplies. The contract has an ultimate completion date of September 23, 2024. CCC is a prime contractor to U.S. federal agencies, primarily the Department of Defense, and has been awarded numerous...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC) for $466,400.00. The contract is for the supply of Reactive Skin Decontamination Lotion (RSDL), a specialized medical product used for chemical warfare agent decontamination. CCC is a Crown corporation owned by the Government of Canada that acts as a prime contractor to U.S. federal agencies, primarily the Department of Defense. This contract does not have a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation of the Government of Canada, for the supply of Reactive Skin Decontamination Lotion (RSDL). The contract has a total ceiling value of $462,000.00 and is a firm fixed-price arrangement. CCC has subcontracted a portion of the work to Emergent Protective Products Canada ULC. The contract does not have a set-aside designation. This order is part of CCC's broader...
- This federal contract award to Canadian Commercial Corporation (CCC), a Canadian government-owned prime contractor, provides the U.S. Defense Logistics Agency (DLA) with Reactive Skin Decontamination Lotion (RSDL) medical supplies. The $209,527.32 firm fixed-price delivery order contract has an ultimate completion date of April 18, 2024. CCC is delivering these mission-critical medical products without any set-aside designation, leveraging its government-to-government contracting expertise to...
- This is a $4,305.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada. The contract is for the delivery of RSDL (Reactive Skin Decontamination Lotion) and has a completion date of February 7, 2025. CCC, which acts as a prime contractor to U.S. federal agencies, will be responsible for supplying this medical equipment. The contract is not associated with any...
- This federal contract award, valued at $4,180.98, was issued by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada that facilitates government-to-government contracting for Canadian exporters. The contract, which is a delivery order, is for the provision of Reactive Skin Decontamination Lotion (RSDL), a medical supply. The contract has no set-aside designation and has an ultimate completion date of April 8, 2025....
- SPE2DP23D0001Indefinite Delivery Contract
- SPE2DP23D0001-SPE2D625F9X6YDelivery Order
The U.S. Department of Defense Medical Supply Chain awarded a $2,090.49 firm fixed-price delivery order (Contract No. 4568409126) to Canadian Commercial Corporation (CCC) on May 30, 2025, with an ultimate completion date of August 14, 2025. This delivery order, which carries no set-aside designation, represents a task order under CCC's existing contract vehicle and leverages the corporation's established government-to-government contracting relationship with U.S. defense agencies. CCC, a Crown corporation of the Government of Canada, serves as a prime contractor facilitating access to Canadian manufacturing and technological capabilities for U.S. federal procurement needs. The contract is to be performed at CCC's location in Ottawa, Ontario, Canada. Under this delivery order, Emergent Biosolutions Canada Inc. serves as the primary subcontractor, manufacturing Reactive Skin Decontamination Lotion (RSDL) for delivery to the Defense Department. RSDL is a medical countermeasure designed to protect against chemical and biological threats, representing a critical component of the department's chemical, biological, radiological, and nuclear (CBRN) defense inventory. Emergent Biosolutions Canada Inc., a for-profit medical countermeasures provider with over $770 million in federal contract history, specializes in manufacturing protective and therapeutic solutions for U.S. government agencies, including the Defense Logistics Agency and Department of Health and Human Services.
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
105929625S | Emergent Biosolutions Canada Inc. | Delivery Order SPE2DP23D0001-SPE2D625F9X6Y | $2.1k | 6/2/25 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 5/30/25 |